Results 91 to 100 of about 15,403 (196)

A ramipril/amlodipin és a lisinopril/amlodipin fix kombinációk a terápiahűség tükrében

open access: yes, 2016
Absztrakt Bevezetés: A hypertonia kezelése során nagy jelentőségű a jó terápiahűség, mivel a célvérnyomás elérésének egyik hangsúlyos eleme.
Simonyi, Gábor   +3 more
core   +1 more source

Toxicodynamic Analysis of Inflammatory Reactions by an Angiotensin Converting Enzyme Inhibitor (Lisinopril) in Guinea-pig Skin

open access: yes, 1995
There have been reports of rash and angioedema in the treatment of hypertension with angiotensin converting enzyme (ACE) inhibitors. To evaluate the inflammatory reaction, we continuously infused lisinopril for three days into the peritoneal cavity of ...
Tatsuji Iga   +3 more
core   +1 more source

Lisinopril effects on platelet activity in patients with arterial hypertension and impaired glucose tolerance

open access: yesРоссийский кардиологический журнал, 2008
The study investigated ACE inhibitor lisinopril (Diroton, Gedeon Richter, Hungary) effects on platelet aggregation in patients with arterial hypertension (AH) and impaired glucose tolerance (IGT).
I. N. Medvedev, O. V. Gamolina
doaj  

Lisinopril in paediatric medicine : a retrospective chart review of long-term treatment in children

open access: yes, 2007
Objective. To investigate the antihypertensive efficacy, dosing, tolerability and effects on growth of lisinopril (off label-use) in paediatric patients during long-term treatment. Design.
Malfait, Fransiska   +4 more
core   +1 more source

Placebo-controlled study of lisinopril in congestive heart failure: A multicentre study

open access: yes, 1987
A double-blind randomised, parallel, placebo-controlled study was performed in patients with congestive heart failure, at 13 centres in 10 countries, to assess the efficacy and safety of lisinopril, a new antiotensin-converting enzyme inhibitor.
Chalmers, John J.P.   +13 more
core  

Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy

open access: yes, 1992
Lisinopril 5–20 mg once daily was compared with digoxin 0.125–0.375 mg once daily in a double-blind, randomized, parallel-group study involving 217 patients with mild-to-moderate heart failure (New York Heart Association [NYHA] grades II–III) who were ...
Herlitz, Johan,
core   +1 more source

Efeito de agentes anti-hipertensivos sobre as células estreladas durante a regeneração hepática em ratos

open access: yesActa Cirúrgica Brasileira, 2000
O efeito de um inibidor da enzima conversora da angiotensina (lisinopril), de um antagonista do receptor da angiotensina II (losartan) e da bradicinina na população de células estreladas (CE) durante o fenômeno regenerativo hepático foi estudado.
Ramalho Fernando S.   +4 more
doaj  

Hemodynamic effects of lisinopril after long-term administration in congestive heart failure.

open access: yes, 1989
To determine whether acute effects of the angiotensin converting enzyme inhibitor lisinopril are maintained during long-term therapy, 19 patients were studied using right-sided heart catheterization before an initial randomized dose of lisinopril and ...
Shah, P K   +8 more
core  

Propafenone and lisinopril therapy effectiveness for sinus rhythm maintenance in patients with persistent atrial fibrillation and arterial hypertension (PROMETEY-III)

open access: yesКардиоваскулярная терапия и профилактика, 1970
Aim. To study effectiveness and safety of combined propafenone and lisinopril therapy for sinus rhythm (SR) maintenance in patients with persistent atrial fibrillation (AF) and arterial hypertension (AH). Material and methods.
R. G. Oganov   +2 more
doaj  

Reversal of pathophysiologic changes with long-term lisinopril treatment in isolated systolic hypertension

open access: yes, 2001
The purpose of this study was to evaluate in a prospective, double-blind, placebo-controlled study the effect of long-term (2-year) lisinopril treatment on cardiovascular end-organ damage in patients with previously untreated isolated systolic ...
Heesen, WF   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy